Asia
In 2025, the Asian Vitamin E market followed a predominantly softening trajectory, driven by persistent oversupply and cautious downstream demand. The year began with weak market sentiment, particularly in China, where excess inventories and competitive pricing among producers led to consistent downward pressure. During the second quarter, sellers actively discounted material to clear stock, while buyers delayed purchases in anticipation of further price corrections. In the second half, the market remained subdued as participants focused on inventory digestion, with procurement largely limited to immediate needs. Although some manufacturers attempted to support prices through export adjustments and controlled output, these efforts had limited success. By the fourth quarter, prices showed early signs of stabilization as market participants moved toward establishing a price floor, though overall demand from animal nutrition, dietary supplements, and personal care sectors remained moderate.
Europe
European Vitamin E prices in 2025 exhibited a gradual downward trend with intermittent stabilization. In Q2, the market remained relatively balanced due to controlled supply and steady procurement, supported by developments such as the restart of production from key manufacturers. However, softer global prices and competitive imports exerted mild downward pressure. In the latter half, prices declined further as demand remained subdued, and buyers adopted cautious purchasing strategies. The lifting of supply constraints had a limited impact due to modest volumes, while non-Chinese material continued to command a premium. By year-end, the market stabilized at lower levels.
North America
In North America, Vitamin E prices fluctuated throughout 2025 but generally trended lower before stabilizing. Early volatility stemmed from tariff-related uncertainties and shifting import dynamics. The mid-year saw continued oscillations as buyers adjusted procurement strategies. In H2, the market stabilized, supported by steady demand from feed, supplements, and personal care sectors, though cautious buying behavior limited upward movement.